Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:471703.
doi: 10.1155/2013/471703. Epub 2013 Oct 9.

Rare variants in the TREX1 gene and susceptibility to autoimmune diseases

Affiliations

Rare variants in the TREX1 gene and susceptibility to autoimmune diseases

Nadia Barizzone et al. Biomed Res Int. 2013.

Abstract

TREX1 (DNase III) is an exonuclease involved in response to oxidative stress and apoptosis. Heterozygous mutations in TREX1 were previously observed in patients with systemic lupus erythematosus (SLE) and Sjögren's syndrome (SS). We performed a mutational analysis of the TREX1 gene on three autoimmune diseases: SLE (210 patients) and SS (58 patients), to confirm a TREX1 involvement in the Italian population, and systemic sclerosis (SSc, 150 patients) because it shares similarities with SLE (presence of antinuclear antibodies and connective tissue damage). We observed 7 variations; two of these are novel nonsynonymous variants (p.Glu198Lys and p.Met232Val). They were detected in one SS and in one SSc patient, respectively, and in none of the 200 healthy controls typed in this study and of the 1712 published controls. In silico analysis predicts a possibly damaging role on protein function for both variants. The other 5 variations are synonymous and only one of them is novel (p.Pro48Pro). This study contributes to the demonstration that TREX1 is involved in autoimmune diseases and proposes that the spectrum of involved autoimmune diseases can be broader and includes SSc. We do not confirm a role of TREX1 variants in SLE.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Scheme of disease-associated TREX1 mutations so far reported in literature. The two missense mutations found in the present study are in squares. Normal type, black: AGS; italic, green: RVCL; underlined, italic, green: CADASIL; underlined black: FCL; boldface, red: SLE; boldface, pink: SSc; boldface, blue: SS. Exo 1, 2, 3 domains; PII: polyproline II domain; TMH: transmembrane domain.

References

    1. Chowdhury D, Beresford PJ, Zhu P, et al. The exonuclease TREX1 is in the SET complex and acts in concert with NM23-H1 to degrade DNA during granzyme a-mediated cell death. Molecular Cell. 2006;23(1):133–142. - PubMed
    1. Christmann M, Tomicic MT, Aasland D, Berdelle N, Kaina B. Three prime exonuclease I (TREX1) is Fos/AP-1 regulated by genotoxic stress and protects against ultraviolet light and benzo(a)pyrene-induced dna damage. Nucleic Acids Research. 2010;38(19):6418–6432. - PMC - PubMed
    1. Morita M, Stamp G, Robins P, et al. Gene-targeted mice lacking the TREX1 (DNase III) 3′→5′ DNA exonuclease develop inflammatory myocarditis. Molecular and Cellular Biology. 2004;24(15):6719–6727. - PMC - PubMed
    1. Lee-Kirsch MA, Gong M, Chowdhury D, et al. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nature Genetics. 2007;39(9):1065–1067. - PubMed
    1. de Vries B, Steup-Beekman GM, Haan J, et al. TREX1 gene variant in neuropsychiatric systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2010;69(10):1886–1887. - PubMed

Publication types

Substances